Celcuity Inc. (CELC) income statement
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$55.60−2.41 (-4.15%)
Close on Nov 18, 2026Market cap $2.72BP/E –Yield –
Celcuity Inc. financial ratios
See a number that looks wrong?
Close on Nov 18, 2026Market cap $2.72BP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Returns on capital | |||||||||||
| Return on equity | -163.8% | -87.5% | -46.6% | -39.9% | -73.6% | -61.1% | -33.0% | -26.4% | -33.8% | -62.3% | – |
| Return on assets | -49.8% | -51.2% | -34.8% | -30.9% | -59.9% | -57.0% | -31.8% | -25.8% | -32.9% | -54.7% | – |
| Return on tangible assets | -49.8% | -51.2% | -34.8% | -30.9% | -59.9% | -57.0% | -31.8% | -25.8% | -32.9% | -54.7% | – |
| Return on invested capital | 115.2% | 700.8% | 2,897.7% | 7,949.1% | 5,058.9% | -11,730.1% | – | – | – | – | – |
| Return on capital employed | -54.2% | -58.0% | -38.3% | -31.2% | -59.6% | -61.4% | -34.9% | -28.0% | -32.2% | -59.3% | – |
| Return on total capital | -78.2% | -58.1% | -38.3% | -31.3% | -59.7% | -81.7% | – | – | – | – | – |
| NOPAT | -$136.03M | -$89.48M | -$52.32M | -$31.12M | -$22.40M | -$7.55M | -$6.17M | -$6.27M | -$4.70M | -$2.63M | – |
| Cash flow quality | |||||||||||
| OCF / Net income | 0.87 | 0.75 | 0.84 | 0.89 | 0.69 | 0.75 | 0.82 | 0.81 | 0.79 | 0.87 | – |
| FCF / OCF | 100.2% | 100.3% | 100.2% | 100.4% | 100.4% | 101.3% | 93.7% | 110.4% | 104.8% | 101.4% | – |
| FCF / Net income | 0.87 | 0.75 | 0.85 | 0.90 | 0.69 | 0.76 | 0.76 | 0.90 | 0.83 | 0.88 | – |
| Unlevered free cash flow | -$139.98M | -$75.60M | -$49.70M | -$34.50M | -$19.40M | -$7.23M | -$6.38M | -$6.71M | -$4.83M | -$2.93M | – |
| Levered free cash flow | -$153.53M | -$83.72M | -$53.91M | -$36.17M | -$20.39M | -$7.24M | -$5.62M | -$6.71M | -$5.19M | -$2.93M | – |
| Efficiency | |||||||||||
| CapEx to OCF | -0.16% | -0.30% | -0.18% | -0.44% | -0.40% | -1.3% | -6.3% | -10.4% | -4.8% | -1.4% | – |
| Liquidity | |||||||||||
| Current ratio | 10.55 | 7.71 | 13.43 | 25.46 | 34.06 | 10.26 | 21.12 | 38.07 | 42.36 | 13.27 | – |
| Quick ratio | 10.55 | 7.71 | 13.43 | 25.46 | 34.06 | 10.26 | 21.12 | 38.07 | 42.36 | 13.27 | – |
| Cash ratio | 10.00 | 7.41 | 12.73 | 24.50 | 33.64 | 9.82 | 20.56 | 37.59 | 41.95 | 13.26 | – |
| Working capital | $421.51M | $212.85M | $176.40M | $168.31M | $82.85M | $10.98M | $18.34M | $24.56M | $23.91M | $5.47M | – |
| Net current asset value | $99.66M | $115.07M | $139.14M | $133.26M | $68.16M | $10.91M | $18.27M | $24.54M | $23.91M | $5.47M | – |
| Leverage | |||||||||||
| Total debt | $126.53M | $97.73M | $37.04M | $34.98M | $14.63M | $0 | – | – | – | – | – |
| Net debt | -$314.97M | -$137.38M | -$143.55M | -$133.60M | -$69.66M | -$11.64M | – | – | – | – | – |
| Debt / Equity | 1.26 | 0.85 | 0.26 | 0.26 | 0.21 | 0.00 | – | – | – | – | – |
| Debt ratio | 27.1% | 39.9% | 19.4% | 19.9% | 17.0% | 0.00% | – | – | – | – | – |
| Assets to equity | 4.64 | 2.12 | 1.37 | 1.31 | 1.25 | 1.11 | 1.05 | 1.03 | 1.02 | 1.08 | – |
| Long-term debt to assets | 27.1% | 39.9% | 19.4% | 19.9% | 17.0% | 0.00% | – | – | – | – | – |
| Long-term debt to equity | 1.26 | 0.85 | 0.26 | 0.26 | 0.21 | 0.00 | – | – | – | – | – |
| Total debt / Capitalization | 55.7% | 45.8% | 20.9% | 20.7% | 17.6% | 0.00% | – | – | – | – | – |
| Long-term debt / Capitalization | 55.7% | 45.8% | 20.9% | 20.7% | 17.6% | 0.00% | – | – | – | – | – |
| Cash flow to debt | -121.1% | -85.4% | -145.3% | -102.9% | -138.9% | – | – | – | – | – | – |
| Interest coverage | |||||||||||
| EBIT / Interest expense | -10.04 | -11.02 | -12.43 | -18.70 | -22.46 | -79,634.70 | -49,089.94 | -71,464.31 | -13.18 | – | – |
| Per share | |||||||||||
| EPS (basic) | -3.79 | -2.83 | -2.69 | -2.64 | -2.21 | -0.92 | -0.72 | -0.74 | -0.84 | -0.52 | – |
| EPS (diluted) | -3.79 | -2.83 | -2.69 | -2.64 | -2.21 | -0.92 | -0.72 | -0.74 | -0.84 | -0.52 | – |
| Book value per share | 2.08 | 3.11 | 5.48 | 6.17 | 4.61 | 1.14 | 1.88 | 2.49 | 3.11 | – | – |
| Tangible book value per share | 2.08 | 3.11 | 5.48 | 6.17 | 4.61 | 1.14 | 1.88 | 2.49 | 3.11 | – | – |
| Cash per share | 9.15 | 6.33 | 7.08 | 7.78 | 5.65 | 1.13 | 1.83 | 2.44 | 2.40 | – | – |
| Operating cash flow per share | -3.18 | -2.25 | -2.11 | -1.66 | -1.36 | -0.69 | -0.59 | -0.60 | -0.49 | – | – |
| Free cash flow per share | -3.18 | -2.25 | -2.11 | -1.67 | -1.37 | -0.70 | -0.55 | -0.66 | -0.51 | – | – |
| CapEx per share | 0.0052 | 0.0067 | 0.0038 | 0.0073 | 0.0055 | 0.0087 | 0.04 | 0.06 | 0.02 | – | – |
| Valuation at period end | |||||||||||
| Market cap | $4.32B | $485.85M | $325.92M | $209.35M | $196.61M | $93.93M | $109.04M | $243.53M | $191.05M | – | – |
| Enterprise value | $3.99B | $318.72M | $228.49M | $166.88M | $120.67M | $80.23M | $88.60M | $220.77M | $158.51M | – | – |
| P/B | 42.9x | 4.2x | 2.3x | 1.6x | 2.9x | 8.0x | 5.7x | 9.6x | 6.1x | – | – |
| P/TBV | 42.9x | 4.2x | 2.3x | 1.6x | 2.9x | 8.0x | 5.7x | 9.6x | 6.1x | – | – |
| P/OCF | -28.2x | -5.8x | -6.1x | -5.8x | -9.7x | -13.1x | -18.2x | -40.1x | -38.6x | – | – |
| EV/OCF | -26.0x | -3.8x | -4.2x | -4.6x | -5.9x | -11.2x | -14.8x | -36.3x | -32.0x | – | – |
| Earnings yield | -4.1% | -23.0% | -19.6% | -19.3% | -15.1% | -10.1% | -6.7% | -3.1% | -3.3% | – | – |
| FCF yield | -3.6% | -17.2% | -16.5% | -17.3% | -10.4% | -7.7% | -5.2% | -2.8% | -2.7% | – | – |
| Per employee | |||||||||||
| Total employees | 155 | 87 | 55 | 45 | 39 | 30 | 27 | 26 | 22 | 22 | 22 |
| Operating profit per employee | -$1.11M | -$1.30M | -$1.20M | -$875.36K | -$727.07K | -$318.54K | -$289.09K | -$305.10K | -$270.59K | -$151.29K | – |
| Net income per employee | -$1.14M | -$1.28M | -$1.16M | -$897.11K | -$759.11K | -$315.81K | -$272.57K | -$287.72K | -$284.17K | -$150.47K | – |
| Free cash flow per employee | -$990.51K | -$962.26K | -$980.18K | -$803.71K | -$522.92K | -$241.17K | -$208.09K | -$257.92K | -$235.81K | -$133.15K | – |
| Growth | |||||||||||
| EBIT 1Y growth | -52.0% | -71.0% | -68.1% | -38.9% | -196.7% | -22.4% | 1.6% | -33.3% | -78.9% | – | – |
| Net income 1Y growth | -58.4% | -75.3% | -58.0% | -36.4% | -212.5% | -28.7% | 1.6% | -19.7% | -88.9% | – | – |
| Diluted EPS 1Y growth | -33.9% | -5.2% | -1.9% | -19.5% | -140.2% | -27.8% | 2.7% | 11.9% | -61.5% | – | – |
| Operating cash flow 1Y growth | -83.6% | -55.1% | -49.4% | -77.3% | -184.3% | -19.1% | 1.3% | -22.8% | -71.3% | – | – |
| Free cash flow 1Y growth | -83.4% | -55.3% | -49.1% | -77.3% | -181.9% | -28.8% | 16.2% | -29.3% | -77.1% | – | – |
| CapEx 1Y growth | -0.40% | 156.0% | -38.5% | 93.9% | -8.4% | -76.5% | -39.6% | 162.5% | 486.4% | – | – |
| CapEx 3Y CAGR | 16.2% | 45.1% | 3.0% | -25.3% | -49.3% | -28.0% | 110.3% | – | – | – | – |
| CapEx 5Y CAGR | 22.7% | -8.0% | -31.1% | -7.9% | 14.9% | – | – | – | – | – | – |
| Total assets 1Y growth | 90.3% | 28.2% | 8.8% | 104.5% | 563.0% | -36.1% | -22.1% | -18.6% | 427.8% | – | – |
| Total assets 3Y CAGR | 38.5% | 41.8% | 145.3% | 105.4% | 48.9% | -26.0% | 49.6% | – | – | – | – |
| Total assets 5Y CAGR | 104.8% | 64.6% | 49.0% | 40.6% | 70.0% | – | – | – | – | – | – |
| Total equity 1Y growth | -13.0% | -17.3% | 4.5% | 94.7% | 487.2% | -39.4% | -23.9% | -19.2% | 459.4% | 11.9% | – |
| Total equity 3Y CAGR | -9.1% | 18.9% | 128.6% | 90.7% | 39.4% | -28.0% | 50.9% | 71.6% | – | – | – |
| Total equity 5Y CAGR | 53.8% | 43.1% | 40.7% | 33.6% | 65.0% | 18.5% | – | – | – | – | – |
| Total equity 10Y CAGR | 35.0% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.